SCHEMBL25762191

SCHEMBL25762191

Cc1cc(-c2ccccc2)cc(S(C)(C)C)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
ACLY P53396 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HTT P42858 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
PSMB5 P28074 1/20 0.36
TSHR P16473 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
FFAR4 Q5NUL3 1/20 0.35
HPGD P15428 1/20 0.35
HPRT1 P00492 1/20 0.35
ADORA2A P29274 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2837502 0.79 ALDH1A1 (0.53) RXRARXRBALDH1A1SMN1; SMN2KDM4E
SCHEMBL1830671 0.79 RXRA (0.54) RXRARXRBALDH1A1SMN1; SMN2KDM4E
SCHEMBL24444327 0.79 ALDH1A1 (0.53) RXRARXRBALDH1A1SMN1; SMN2KDM4E
SCHEMBL8475151 0.79 CA2 (0.57) CA1CA2CA9
SCHEMBL27471611 0.77 RXRA (0.58) RXRARXRBALDH1A1SMN1; SMN2KDM4E
SCHEMBL23056988 0.76 MGLL (0.45) ALDH1A1CA1CA2CA9NPC1
SCHEMBL23518713 0.75 MAOA (0.48) RXRARXRBALDH1A1SMN1; SMN2KDM4E
SCHEMBL14036343 0.75 MAOA (0.48) RXRARXRBALDH1A1SMN1; SMN2KDM4E
SCHEMBL598686 0.74 TSHR (0.53) RXRARXRBALDH1A1SMN1; SMN2KDM4E
SCHEMBL19451097 0.74 ALDH1A1 (0.42) ALDH1A1CA1CA9HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217811-A1 COMPOUNDS AND ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217811-A1 COMPOUNDS AND ORGANIC ELECTRONIC DEVICES ETV6, CYP2C19, AFF2 RXRA 1095/4885RXRB 1339/4885ACLY 3501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.